A genome-wide CRISPR screen identifies regulation factors of the TLR3 signalling pathway.


Journal

Innate immunity
ISSN: 1753-4267
Titre abrégé: Innate Immun
Pays: United States
ID NLM: 101469670

Informations de publication

Date de publication:
08 2020
Historique:
pubmed: 7 4 2020
medline: 1 10 2021
entrez: 7 4 2020
Statut: ppublish

Résumé

A subset of TLRs is specialised in the detection of incoming pathogens by sampling endosomes for nucleic acid contents. Among them, TLR3 senses the abnormal presence of double-stranded RNA in the endosomes and initiates a potent innate immune response via activation of NF-κB and IRF3. Nevertheless, mechanisms governing TLR3 regulation remain poorly defined. To identify new molecular players involved in the TLR3 pathway, we performed a genome-wide screen using CRISPR/Cas9 technology. We generated TLR3

Identifiants

pubmed: 32248720
doi: 10.1177/1753425920915507
pmc: PMC7491238
doi:

Substances chimiques

CXCL10 protein, human 0
Chemokine CXCL10 0
IRF3 protein, human 0
Interferon Regulatory Factor-3 0
Interleukin-8 0
Membrane Transport Proteins 0
NF-kappa B 0
Receptors, Aryl Hydrocarbon 0
Toll-Like Receptor 3 0
UNC93B1 protein, human 0
Poly I-C O84C90HH2L

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

459-472

Subventions

Organisme : Wellcome Trust
ID : 210688/Z/18/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/V011561/1
Pays : United Kingdom

Références

PLoS One. 2013 Jul 08;8(7):e70339
pubmed: 23861985
Science. 2003 Aug 1;301(5633):640-3
pubmed: 12855817
Biochim Open. 2018 Jun 11;7:1-9
pubmed: 30003042
PLoS One. 2011;6(12):e28500
pubmed: 22164301
Cell Metab. 2016 Nov 8;24(5):740-752
pubmed: 27923773
Exp Cell Res. 1999 Nov 1;252(2):273-80
pubmed: 10527618
Int Immunopharmacol. 2015 Oct;28(2):818-24
pubmed: 25907242
Nature. 2014 Jul 10;511(7508):184-90
pubmed: 24930766
Arthritis Rheum. 2005 Sep;52(9):2656-65
pubmed: 16142732
EMBO J. 2006 Jul 26;25(14):3335-46
pubmed: 16858407
Nat Commun. 2016 Jun 10;7:11786
pubmed: 27283361
Biochem Pharmacol. 2000 Jan 1;59(1):65-85
pubmed: 10605936
Genes Dev. 2012 Feb 1;26(3):203-34
pubmed: 22302935
Sci Signal. 2012 Jul 17;5(233):ra50
pubmed: 22810896
Nature. 2014 May 22;509(7501):487-91
pubmed: 24717434
J Virol. 2017 Jul 12;91(15):
pubmed: 28490595
J Biol Chem. 1998 Jan 30;273(5):2895-904
pubmed: 9446600
Int J Dev Biol. 2000;44(6):619-26
pubmed: 11061425
Science. 2014 Jan 3;343(6166):84-87
pubmed: 24336571
Arch Toxicol. 2017 May;91(5):2209-2221
pubmed: 27783115
Carcinogenesis. 2018 Apr 5;39(4):614-622
pubmed: 29562322
Nat Rev Immunol. 2007 May;7(5):353-64
pubmed: 17457343
J Biol Chem. 2005 Nov 4;280(44):37107-17
pubmed: 16105838
J Biol Chem. 2012 Sep 21;287(39):32617-29
pubmed: 22865861
Nature. 2006 Jan 12;439(7073):208-11
pubmed: 16306936
Science. 2006 Oct 13;314(5797):308-12
pubmed: 16973841
Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3533-8
pubmed: 14982987
Front Immunol. 2014 Sep 25;5:461
pubmed: 25309543
J Biol Chem. 2005 Nov 4;280(44):36560-6
pubmed: 16115877
Annu Rev Immunol. 2014;32:403-32
pubmed: 24655296
J Neuroimmunol. 2007 Jan;182(1-2):89-99
pubmed: 17097745
Nat Rev Immunol. 2009 Aug;9(8):535-42
pubmed: 19556980
Immunity. 2010 Mar 26;32(3):305-15
pubmed: 20346772
Nature. 2001 Oct 18;413(6857):732-8
pubmed: 11607032
J Biol Chem. 1993 Sep 5;268(25):19092-100
pubmed: 8395529
Sci Immunol. 2017 Jul 7;2(13):
pubmed: 28783704
J Biol Chem. 1988 Sep 25;263(27):13802-5
pubmed: 2843537
Nature. 2008 Mar 13;452(7184):234-8
pubmed: 18305481
Biochem Biophys Res Commun. 2007 Nov 23;363(3):722-6
pubmed: 17900530
Immunology. 2014 Mar;141(3):353-61
pubmed: 24708416
J Immunol. 2002 Dec 15;169(12):6668-72
pubmed: 12471095
Nat Immunol. 2006 Feb;7(2):156-64
pubmed: 16415873
Proc Natl Acad Sci U S A. 2012 Jun 5;109(23):9053-8
pubmed: 22611194
J Exp Med. 2009 Jan 16;206(1):43-9
pubmed: 19114668
Mol Endocrinol. 2007 Dec;21(12):2941-55
pubmed: 17823304
Chem Biol. 1995 Dec;2(12):841-5
pubmed: 8807817
Nat Methods. 2014 Aug;11(8):783-784
pubmed: 25075903
Immunity. 2018 May 15;48(5):911-922.e7
pubmed: 29768176
J Exp Med. 2009 Aug 31;206(9):2027-35
pubmed: 19703987
Elife. 2013 Feb 19;2:e00291
pubmed: 23426999
J Immunol. 2003 Oct 15;171(8):4304-10
pubmed: 14530355
Oncogene. 2012 May 17;31(20):2555-65
pubmed: 21996739
J Exp Med. 2011 Apr 11;208(4):643-51
pubmed: 21402738
Immunity. 2002 Sep;17(3):251-63
pubmed: 12354379
Nat Rev Immunol. 2004 Jul;4(7):499-511
pubmed: 15229469
Biochem Pharmacol. 2009 Feb 15;77(4):670-80
pubmed: 19014911
Science. 2010 Sep 10;329(5997):1345-8
pubmed: 20688981
Arthritis Res Ther. 2010;12(3):R103
pubmed: 20500834
Virology. 2015 May;479-480:104-9
pubmed: 25800355
J Biol Chem. 2005 Nov 18;280(46):38133-45
pubmed: 16144834
J Cell Biol. 2007 Apr 23;177(2):265-75
pubmed: 17452530
Biochemistry. 1999 Jul 13;38(28):8907-17
pubmed: 10413464
Sci STKE. 2006 Oct 17;2006(357):re13
pubmed: 17047224
Curr Opin Immunol. 2013 Feb;25(1):19-33
pubmed: 23290562
J Cell Sci. 2017 Oct 1;130(19):3234-3247
pubmed: 28775154
Immunity. 2018 Jan 16;48(1):19-33
pubmed: 29343438
Science. 2007 Sep 14;317(5844):1522-7
pubmed: 17872438

Auteurs

Laurent Zablocki-Thomas (L)

Institut Curie, PSL Research University, INSERM U932, France.

Sam A Menzies (SA)

Department of Medicine, Cambridge Institute for Medical Research, Cambridge Biomedical Campus, UK.

Paul J Lehner (PJ)

Department of Medicine, Cambridge Institute for Medical Research, Cambridge Biomedical Campus, UK.

Nicolas Manel (N)

Institut Curie, PSL Research University, INSERM U932, France.

Philippe Benaroch (P)

Institut Curie, PSL Research University, INSERM U932, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH